Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 2Urinary Bladder Neoplasms 1Terminal Cancer 1Solid Tumor 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Cognitive Complications 1Polyps 1Patient Satisfaction 1Pancreatitis 1Pancreatic Neoplasms 1Pain, Postoperative 1Pain 1Mouth Neoplasms 1Gastrointestinal Stromal Tumors 1Fractures, Bone 1Colonic Neoplasms 1Choledocholithiasis 1Choledochal Cyst 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Anxiety Disorders 1

Interventions

olutasidenib 1lenvatinib 1Sevoflurane 1Oxaliplatin 1Nutritional Status 1Midazolam 1Meperidine 1Folfox protocol 1Etomidate 1Enteral Nutrition 1Eicosapentaenoic Acid 1Diet 1Desflurane 1Cytochrome P-450 CYP3A 1Cytochrome P-450 CYP2C9 1Cytochrome P-450 CYP2C8 1Cytochrome P-450 CYP2C19 1Cytochrome P-450 CYP2B6 1Cytochrome P-450 CYP1A2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Cholangiocarcinoma × Midazolam × Clear all
NCT02027311 2015-06-29

Etomidate vs. Midazolam for Sedation During ERCP

Cheju Halla General Hospital

Phase 4 Completed
63 enrolled 9 charts
Gastrointestinal

Pancreatic Neoplasms, Pancreatitis, Cholangiocarcinoma, Choledocholithiasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡